Evidence map›Paper›PMID 15919820›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2005

Distinct effectors of platelet-derived growth factor receptor-alpha signaling are required for cell survival during embryogenesis.

Melanie Van Stry, Andrius Kazlauskas, Stuart L Schreiber, Karen Symes

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The Genetics of Fetal Alcohol Spectrum Disorders.Alcoholism, clinical and experimental research · 2016
    Review
  7. Article
  8. Review
  9. Article
  10. Reversal of experimental pulmonary hypertension by PDGF inhibition.The Journal of clinical investigation · 2005
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Melanie Van StryDepartment of Biochemistry, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118, USA.
Andrius Kazlauskas
Stuart L Schreiber
Karen Symes
Harvard University · USHoward Hughes Medical Institute · US

Funding

PDGF and PVRR01EY012509 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI LEI, HETIAN · 2000 to 2017
$8.5M
PRE- AND POSTDOCTORAL TRAINING IN BIOCHEMISTRY OF AGINGT32AG000115 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI POLGAR, PETER RUDOLPH · 1985 to 2012
$4.3M
CELL MOVEMENT DURING XENOPUS DEVELOPMENT--METASTASISR01CA087375 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI SYMES, KAREN · 2000 to 2004
$1.3M
Rapamycin-sensitive pathway of T cell ActivationZ01AG000115 · NIA · NATIONAL INSTITUTE ON AGING · PI LONGO, DAN L. · 2000 to 2008
$762k
Intramural NIH HHS Z01 AG000115NCI NIH HHS CA87375NCI NIH HHS R01 CA087375NEI NIH HHS EY012509NEI NIH HHS R01 EY012509NIA NIH HHS T32 AG000115
6 · The paper itself

Abstract

Platelet-derived growth factor receptor (PDGFR) signaling is essential for normal embryonic development in many organisms, including frog, mouse, zebrafish, and sea urchin. The mode of action of PDGFR signaling during early development is poorly understood, however, mostly because inhibition of signaling through either the PDGFRalpha or PDGFRbeta is embryonic lethal. In Xenopus embryos, disruption of PDGFRalpha signaling causes migrating anterior mesoderm cells to lose direction and undergo apoptosis through the mitochondrial pathway. To understand the mechanism of PDGFRalpha function in this process, we have analyzed all known effector-binding sites in vivo. By using a chemical inducer of dimerization to activate chimera PDGFRalphas, we have identified a role for phospholipase Cgamma (PLCgamma) in protecting cells from death. PDGFRalpha-mediated cell survival requires PLCgamma and phosphatidylinositol 3-kinase signaling, and that PDGFRalpha with binding sites for these two signaling factors is sufficient for this activity. Other effectors of PDGFRalpha signaling, Shf, SHP-2, and Crk, are not required for this process. Thus, our findings show that PDGFRalpha signaling through PLCgamma and phosphatidylinositol 3-kinase has a protective role in preventing apoptosis in early development. Furthermore, we demonstrate that small molecule inducers of dimerization provide a powerful system to manipulate receptor function in developing embryos.

Indexed as

Embryonic DevelopmentSignal TransductionAnimalsCell SurvivalEmbryo, NonmammalianIntracellular Signaling Peptides and ProteinsMesodermPhosphatidylinositol 3-KinasesPhospholipase C gammaPhosphoproteinsProtein Tyrosine Phosphatase, Non-Receptor Type 11Protein Tyrosine PhosphatasesProto-Oncogene ProteinsProto-Oncogene Proteins c-crkReceptors, Platelet-Derived Growth FactorType C Phospholipasescrk2 protein, XenopusIntracellular Signaling Peptides and ProteinsPhosphatidylinositol 3-KinasesPhospholipase C gammaPhosphoproteinsProtein Tyrosine Phosphatase, Non-Receptor Type 11Protein Tyrosine PhosphatasesProto-Oncogene ProteinsProto-Oncogene Proteins c-crkPtpn11 protein, mouseReceptors, Platelet-Derived Growth FactorType C PhospholipasesTyrosineXenopus Proteins

Identifiers

PMID15919820
PMCPMC1149433
OpenAlexW2083009328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.